First Trust Advisors LP Vericel Corp Transaction History

First Trust Advisors LP

$118 Billion
Q2 2025

A detailed history of First Trust Advisors LP transactions in Vericel Corp stock. As of the latest transaction made, First Trust Advisors LP holds 41,432 shares of VCEL stock, worth $1.44 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

41,432

Previous 93,485 55.68%

Holding current value

$1.44 Million

Previous $4.17 Million 57.76%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	SELL	$37.92 - $45.7 $1.97 Million - $2.38 Million	-52,053 Reduced 55.68%	41,432 $1.76 Million
Q1 2025 May 14, 2025	BUY	$44.5 - $61.8 $3.93 Million - $5.46 Million	88,343 Added 1718.07%	93,485 $4.17 Million
Q4 2024 Feb 13, 2025	SELL	$40.05 - $59.11 $1.07 Million - $1.58 Million	-26,776 Reduced 83.89%	5,142 $282,000
Q3 2024 Nov 13, 2024	SELL	$42.25 - $53.56 $2.53 Million - $3.2 Million	-59,832 Reduced 65.21%	31,918 $1.35 Million
Q2 2024 Aug 13, 2024	BUY	$41.71 - $52.9 $2.29 Million - $2.91 Million	55,006 Added 149.7%	91,750 $4.21 Million
Q1 2024 May 13, 2024	SELL	$32.52 - $52.33 $680,546 - $1.1 Million	-20,927 Reduced 36.29%	36,744 $1.91 Million
Q4 2023 Feb 13, 2024	SELL	$30.85 - $37.09 $678,545 - $815,794	-21,995 Reduced 27.61%	57,671 $2.05 Million
Q3 2023 Nov 13, 2023	BUY	$31.69 - $39.25 $1.33 Million - $1.65 Million	41,979 Added 111.39%	79,666 $2.67 Million
Q2 2023 Aug 14, 2023	BUY	$29.0 - $38.37 $224,634 - $297,214	7,746 Added 25.87%	37,687 $1.42 Million
Q1 2023 May 15, 2023	BUY	$23.85 - $31.34 $714,092 - $938,350	29,941 New	29,941 $877,000
Q3 2022 Nov 14, 2022	SELL	$22.62 - $32.54 $501,055 - $720,793	-22,151 Reduced 66.55%	11,134 $258,000
Q2 2022 Aug 12, 2022	BUY	$22.88 - $39.45 $524,157 - $903,760	22,909 Added 220.79%	33,285 $838,000
Q1 2022 May 13, 2022	SELL	$31.69 - $43.29 $724,528 - $989,739	-22,863 Reduced 68.78%	10,376 $397,000
Q4 2021 Feb 08, 2022	SELL	$35.2 - $52.6 $1.08 Million - $1.62 Million	-30,709 Reduced 48.02%	33,239 $1.31 Million
Q3 2021 Nov 15, 2021	SELL	$46.35 - $59.75 $2 Million - $2.57 Million	-43,096 Reduced 40.26%	63,948 $3.12 Million
Q2 2021 Aug 16, 2021	BUY	$47.2 - $67.81 $5.05 Million - $7.26 Million	107,044 New	107,044 $5.62 Million

Others Institutions Holding VCEL

# of Institutions

294

Shares Held

54M

Call Options Held

35.6K

Put Options Held

7.7K

View Full List

About Vericel Corp

Ticker VCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,178,000
Market Cap $1.63B
Description
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...

More about VCEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on First Trust Advisors LP with notifications on news.

Account

First Trust Advisors LP Vericel Corp Transaction History